<b>Methods</b>: Here, we investigated whether chronic high-dose CBD treatment (i.e., 100 mg/kg intraperitoneally) in early symptomatic 7.5-month-old <i>APP/PS1</i> males would reverse cognitive deficits while also influencing neuropathological markers relevant to AD. The gene discussed is APP; the disease is Cognitive impairment.